Sponsor Pipeline

GLSMED Learning Health S.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07316621
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives		 Recruitment opened
2026-07-30 NCT07316621
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives		 Primary endpoint(s) modified
2026-07-30 NCT07316621
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives		 Trial sites expanded: 0 -> 10 locations
2026-07-29 NCT05420233
The CROCO Study: CROhn's Disease COhort Study		 Enrollment closed, study ongoing
2026-07-29 NCT05420233
The CROCO Study: CROhn's Disease COhort Study		 Enrollment reduced: 600 -> 533 participants
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06727253 Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression Crohn Disease (CD) Recruiting
NCT07316621 Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives Crohn Disease (CD) Recruiting
NCT05420233 The CROCO Study: CROhn's Disease COhort Study Crohn Disease Active, Not Recruiting
Disease Areas
Crohn's Disease (3)
Get alerts when GLSMED Learning Health S.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free